Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancoast Syndrome × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 640 Lung Neoplasms 277 Ovarian Neoplasms 274 Breast Neoplasms 227 Fallopian Tube Neoplasms 135 Neoplasms 116 Small Cell Lung Carcinoma 115 Triple Negative Breast Neoplasms 113 Squamous Cell Carcinoma of Head and Neck 101 Carcinoma, Ovarian Epithelial 100 Neoplasm Metastasis 71 Head and Neck Neoplasms 66 Endometrial Neoplasms 63 Uterine Cervical Neoplasms 56 Adenocarcinoma of Lung 56 Esophageal Neoplasms 54 Brain Neoplasms 45 Central Nervous System Neoplasms 44 Recurrence 41 Prostatic Neoplasms 40 Lymphoma, Large B-Cell, Diffuse 39 Carcinoma 39 Neuroblastoma 38 Parkinson Disease 4, Autosomal Dominant Lewy Body 37 Urinary Bladder Neoplasms 36 Lymphoma 33 Esophageal Squamous Cell Carcinoma 33 Carcinoma, Squamous Cell 30 Melanoma 28 Colorectal Neoplasms 27

Interventions

Cisplatin 2 durvalumab 1 belinostat 1 Vindesine 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Mitomycin 1 Fluorouracil 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684276 2025-04-10

DUMAS

Fundación GECP

Phase 2 Recruiting

Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡